title: Emergency department utilization among HIV-infected patients in a multisite multistate study.
abstract: OBJECTIVE
  The aim of this study was to examine Emergency Department (ED) utilization and clinical and sociodemographic correlates of ED use among HIV-infected patients.
  
  
  METHODS
  During 2003, 951 patients participated in face-to-face interviews at 14 HIV clinics in the HIV Research Network. Respondents reported the number of ED visits in the preceding 6 months. Using logistic regression, we identified factors associated with visiting the ED in the last 6 months and admission to the hospital from the ED.
  
  
  RESULTS
  Thirty-two per cent of respondents reported at least one ED visit in the last 6 months. In multivariate analysis, any ED use was associated with Medicaid insurance, high levels of pain (the third or fourth quartile), more than seven primary care visits in the last 6 months, current or former illicit drug use, social alcohol use and female gender. Of those who used ED services, 39% reported at least one admission to the hospital. Patients with pain in the highest quartile reported increased admission rates from the ED as did those who made six or seven primary care visits, or more than seven primary care visits vs. three or fewer.
  
  
  CONCLUSIONS
  The likelihood of visiting the ED has not diminished since the advent of highly active antiretroviral therapy (HAART). More ED visits are to treat illnesses not related to HIV or injuries than to treat direct sequelae of HIV infection. With the growing prevalence of people living with HIV infection, the numbers of HIV-infected patients visiting the ED may increase, and ED providers need to understand potential complications produced by HIV disease.
authors.affiliation: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Josephs
authors.forename: J A
authors.initials: JA
authors.lastname: Fleishman
authors.forename: P T
authors.initials: PT
authors.lastname: Korthuis
authors.forename: R D
authors.initials: RD
authors.lastname: Moore
authors.forename: K A
authors.initials: KA
authors.lastname: Gebo
mesh_terms: D000293:Adolescent; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D003430:Cross-Sectional Studies; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data*; D005260:Female; D015658:HIV Infections / Q000628:therapy*; D020276:HIV Long-Term Survivors; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data*; D012959:Socioeconomic Factors; D019966:Substance-Related Disorders / Q000150:complications; D013997:Time Factors; D014481:United States; D055815:Young Adult
references.citation: Med Care. 2005 Sep;43(9 Suppl):III23-30
references.pmid: 16116306
references.citation: N Engl J Med. 1997 Sep 11;337(11):725-33
references.pmid: 9287227
references.citation: Am J Med Sci. 2004 Dec;328(6):305-14
references.pmid: 15599325
references.citation: Ann Emerg Med. 2008 Aug;52(2):108-15
references.pmid: 18407374
references.citation: Drug Alcohol Depend. 2001 Sep 1;64(1):55-62
references.pmid: 11470341
references.citation: N Engl J Med. 1998 Dec 24;339(26):1897-904
references.pmid: 9862946
references.citation: Med Care. 2005 Sep;43(9 Suppl):III40-52
references.pmid: 16116308
references.citation: J Subst Abuse Treat. 2003 Jul;25(1):37-42
references.pmid: 14512106
references.citation: J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):102-10
references.pmid: 14501801
references.citation: J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):96-103
references.pmid: 15608532
references.citation: AIDS Care. 2004 Aug;16(6):744-55
references.pmid: 15370062
references.citation: Health Serv Res. 1983 Spring;18(1):49-74
references.pmid: 6841113
references.citation: Am J Epidemiol. 2002 Apr 15;155(8):760-70
references.pmid: 11943695
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):253-61
references.pmid: 9495226
references.citation: JAMA. 1999 Jun 23-30;281(24):2305-15
references.pmid: 10386555
references.citation: MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19
references.pmid: 1361652
references.citation: N Engl J Med. 1998 Mar 26;338(13):853-60
references.pmid: 9516219
references.citation: Lancet. 2005 Jul 30-Aug 5;366(9483):378-84
references.pmid: 16054937
references.citation: J Health Soc Behav. 1995 Mar;36(1):1-10
references.pmid: 7738325
references.citation: Health Serv Res. 1994 Dec;29(5):527-48
references.pmid: 8002348
references.citation: Ann Emerg Med. 2000 Jan;35(1):63-8
references.pmid: 10613941
references.citation: BMJ. 1997 Nov 8;315(7117):1194-9
references.pmid: 9393221
references.citation: Soc Sci Med. 2000 Jun;50(12):1703-13
references.pmid: 10798326
references.citation: J Stud Alcohol. 2002 Mar;63(2):179-86
references.pmid: 12033694
references.citation: AIDS. 1997 Oct;11(12):F101-5
references.pmid: 9342061
references.citation: Acad Emerg Med. 2003 Apr;10(4):320-8
references.pmid: 12670845
references.citation: Recent Dev Alcohol. 2001;15:285-98
references.pmid: 11449748
references.citation: AIDS. 2004 Mar 5;18(4):621-30
references.pmid: 15090767
references.citation: J Acquir Immune Defic Syndr. 1999 Aug 1;21(4):293-300
references.pmid: 10428107
references.citation: N Engl J Med. 1997 May 22;336(21):1531-2
references.pmid: 9157292
references.citation: Ann Fam Med. 2003 Jul-Aug;1(2):81-9
references.pmid: 15040437
references.citation: Acad Emerg Med. 2003 Nov;10(11):1228-38
references.pmid: 14597499
references.citation: Adv Data. 2003 Jun 4;(335):1-29
references.pmid: 12822264
references.citation: Ann Emerg Med. 2006 Jul;48(1):1-8
references.pmid: 16781914
references.citation: Health Serv Res. 1994 Oct;29(4):489-510
references.pmid: 7928374
references.citation: J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):165-73
references.pmid: 14526205